HB

Helene Le Buanec

NE Neovacs: 5 patents #4 of 21Top 20%
CN CNRS: 2 patents #1,756 of 11,908Top 15%
UC Université Paris Cité: 1 patents #123 of 608Top 25%
U7 Université Paris Diderot—Paris 7: 1 patents #80 of 323Top 25%
Overall (All Time): #710,817 of 4,157,543Top 20%
7
Patents All Time

Issued Patents All Time

Showing 1–7 of 7 patents

Patent #TitleCo-InventorsDate
11365392 Ex vivo generation of MHCII restricted CD4+ FOXP3+ regulatory T cells and therapeutic uses thereof Daniel Zagury, Sophie Duchez, Valerie Schiavon, Armand Bensussan 2022-06-21
11198851 Ex vivo generation of γδ Foxp3+ regulatory T cells and therapeutic uses thereof Daniel Zagury, Sophie Duchez, Valerie Schiavon, Armand Bensussan 2021-12-14
8679483 High-yield method for the production of human antibodies blocking the biological activity of a human cytokine Bernard Bizzini, Daniel Zagury 2014-03-25
8372388 Method for preparing a stable TNF-α vaccine Daniel Zagury 2013-02-12
8101165 Use of immunogens to treat or prevent, in malignant tumors, the immune or vascular disorders induced by extracellular factors Jean-Francois Zagury, Bernard Bizzini, Daniel Zagury 2012-01-24
7887811 Method for preparing a stable immunogenic product comprising antigenic heterocomplexes of TNFα and a carrier protein Daniel Zagury 2011-02-15
7314629 Non-immunosuppressive immunogenic or vaccine composition comprising a mutated E7 protein of the HPV-16 virus Daniel Zagury, Bernard Bizzini 2008-01-01